Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The balanced receptor activation profilewith relatively stronger GIP receptor effects balanced by GLP-1 and glucagon activationoptimizes efficacy while managing safety considerations
Summary Keywords metabolite, biomarker, major depressive disorder, acetylcarnitine, remission status, drug treatment Citation Lee S, Mun S, Lee Y-R, Choi H, Joo E-J, Kang H-G and Lee J (2022) Discovery and validation of acetyl-L-carnitine in serum for diagnosis of major depressive disorder and remission status through metabolomic approach
doi:10.1016/j.jhepr.2020.100192 6
Long-term risks are unknown
US$ 28.52
US$ 22.56
US$ 27.45
US$ 28.92
US$ 24.10
US$ 27.25
US$ 20.97
US$ 27.85
US$ 29.08
US$ 26.13
US$ 28.53
US$ 21.01
US$ 27.40
US$ 25.67
